Tamar Thompson is a health policy and reimbursement strategist with extensive experience working with governmental agencies, private payers, Congressional leaders, and patient advocacy groups to improve patient access to existing and new medical therapies. She has more than 15 years of leadership experience in health care, including the ability to develop strategic and tactical recommendations to ensure optimal reimbursement and market access for products.

Prior to joining HillCo Health, Ms. Thompson was a strategic policy advisor and consultant for two Washington DC based firms, Kimbell & Associates and Avalere Health, where she managed a diverse portfolio of clients, including medical device, biotech, pharmaceutical , and specialty drug, companies.

Preceding her time in Washington DC, Ms. Thompson was Director of Health Policy & Reimbursement at Molecular Insight Pharmaceuticals (MIP), charged with developing and launching reimbursement strategy for cutting-edge molecular diagnostic and therapeutic treatments options. She has also leadership reimbursement strategy at GE Healthcare and Bracco Diagnostics. Ms. Thompson has served as claims operations director and benefit plan manager in the managed care sector for Humana and ValueOptions.

Ms. Thompson holds a M.S. in Health Sciences with a concentration in Public Health from Trident University in Cypress California. She also has active certifications from the American Health Information Management Association (AHIMA) as a Certified Coding Specialist (CCS) and Certified Coding Specialist – Physician Based (CCS-P).